RxDoctor Payments Data

Jennifer Beair, MD

Obstetrics & Gynecology · Honolulu, HINPI 1417367780

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Amgen at 46.7% of the total. Reporting peaked in 2019 at $951 and has fallen 68.4% since, to $301 in 2025.

$2,615in general payments, 2019–2025

Across 77 payments — averaging $33.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$1K
  • Hologic Sales And Service, LLC$261
  • Radius Health, Inc.$233
  • Organon$194
  • Gen-probe Sales & Service, Inc.$108
  • Bayer$98
  • plus $500 from 12 others

What the payments were for

  • Food & beverage$2,608100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,615 in reported general payments places this provider in the 85th percentile of 225 obstetrics & gynecology providers in Hawaii.

See all obstetrics & gynecology providers in Hawaii

Medicare billing

Part B allowed, 2024
$7,511
Medicare patients
48
Services billed
104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
YuvafemEstradiol36$6,753
Alendronate Sodium108$3,123
ProgesteroneProgesterone, Micronized11$1,071

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →